Navigation Links
Perinatal Days and International Stillbirth Conference -- Nov.5-7
Date:9/30/2008

The 21st Norsk Perinataldager (Norwegian Perinatal Days) will be arranged as a joint conference with the 2008 International Stillbirth Conference from the 5th 7th November. This is in collaboration with the International Stillbirth Allliance (ISA) and the World Health Organisation (WHO). The Norwegian Institute of Public Health (NIPH) is chairing the conference and many researchers from the NIPH will present research on stillbirth and research from the Norwegian Mother and Child Cohort Study. It is not too late to register.

Prevention of stillbirth in developing countries is given a particular focus on the opening day of this year's conference. The following two days concentrate on prevention of growth-restriction in children, better care and health services. There is also a programme about important themes for Norwegian pregnancy and newborn health (in Norwegian). The conference has a long list of international speakers and programmes for health professionals, parents and researchers. NORAD is sponsoring participants from the developing countries.

The Norwegian Society for Perinatal Medicine, The Norwegian SIDS and Stillbirth Society and Rikshospitalet Perinatal Research Center are the hosts of the conference, which will take place at the Radisson SAS Plaza Hotel in Oslo on the 5th -7th November.

Each day will begin with a joint session at 9 a.m. and continue with three to five parallel sessions. Free movement is allowed between the different halls, allowing you to pick out the the most relevant topics from each conference.


'/>"/>

Contact: Frederik Fren
frederik.froen@fhi.no
Norwegian Institute of Public Health
Source:Eurekalert

Page: 1

Related biology news :

1. Sentara begins international trial -- open at only 24 US locations
2. BIO-key(R) International To Exhibit at Oracle OpenWorld
3. McGill conference on Global Food Crisis draws impressive list of international participants
4. International TGen-led team finds link between brain protein and Alzheimers disease
5. International experts collect alpine fungi in Beartooth Mountains of Montana
6. Corporate Safe Specialists Launches International Sales Efforts
7. International team reveals first prognosticator of survival in aggressive cancer
8. [video] Michael DePasquale, CEO of BIO-key International, Inc., Discusses Q2 2008 Revenue Growth on WallSt.nets 3-Minute Press Show
9. NYU Langone Medical Centers tip sheet to the International Conference on Alzheimers Disease 2008
10. International conference to release new findings on smell and taste
11. International team identifies 21 new genetic risk factors for Crohns disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2016)... R.I. , March 31, 2016  Genomics firm ... of founding CEO, Barrett Bready , M.D., who ... members of the original technical leadership team, including Chief ... President of Product Development, Steve Nurnberg and Vice President ... returned to the company. Dr. Bready served ...
(Date:3/23/2016)... March 23, 2016 ... Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender Anbieter ... Unternehmen mit SpeechPro zusammenarbeitet, um erstmals dessen ... wird die Möglichkeit angeboten, im Rahmen mobiler ...
(Date:3/22/2016)... Ontario , PROVO and ... Newborn Screening Ontario (NSO), which operates the ... for molecular testing, and Tute Genomics and UNIConnect, ... management technology respectively, today announced the launch of a ... next-generation sequencing (NGS) testing panel. NSO ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers ... the 6000i models are higher end machines that use the more unconventional z-dimension of ... beam from the bottom of the cuvette holder. , FireflySci has developed several ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology: